Cargando…

New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases

Iron chelation has been introduced as a new therapeutic concept for the treatment of neurodegenerative diseases with features of iron overload. At difference with iron chelators used in systemic diseases, effective chelators for the treatment of neurodegenerative diseases must cross the blood–brain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuñez, Marco T., Chana-Cuevas, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316457/ https://www.ncbi.nlm.nih.gov/pubmed/30347635 http://dx.doi.org/10.3390/ph11040109

Ejemplares similares

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
por: Fulgenzi, Alessandro, et al.
Publicado: (2020)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Potential Treatment of Retinal Diseases with Iron Chelators
por: Shu, Wanting, et al.
Publicado: (2018)

Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
por: Mounsey, Ross B., et al.
Publicado: (2012)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
por: Sales, Thais A., et al.
Publicado: (2019)

Effect of Systemic Iron Overload and a Chelation Therapy in a Mouse Model of the Neurodegenerative Disease Hereditary Ferritinopathy
por: Garringer, Holly J., et al.
Publicado: (2016)

New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications
por: Kontoghiorghes, George J., et al.
Publicado: (2021)

Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases
por: Kontoghiorghes, George J., et al.
Publicado: (2020)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence
por: Chong, Chia Chee, et al.
Publicado: (2021)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Neuron Protection by EDTA May Explain the Successful Outcomes of Toxic Metal Chelation Therapy in Neurodegenerative Diseases
por: Ferrero, Maria Elena
Publicado: (2022)

Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
por: Zeng, Xiaoyan, et al.
Publicado: (2021)

Using substantial reductant concentration with chelation therapy to enhance small aggregate dispersal, iron mobilization, and its clearance in neurodegenerative diseases
por: Muhoberac, Barry B.
Publicado: (2022)

Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion
por: Hershko, Chaim, et al.
Publicado: (1994)

Regional siderosis: a new challenge for iron chelation therapy
por: Cabantchik, Zvi Ioav, et al.
Publicado: (2013)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases
por: Ben-Shushan, Shira, et al.
Publicado: (2021)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
por: Eziefula, Chinea, et al.
Publicado: (2022)

The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators
por: Habib, Hosam M., et al.
Publicado: (2021)

Advances in iron chelation therapy: transitioning to a new oral formulation
por: Shah, Nirmish R.
Publicado: (2017)

Adherence to Iron Chelation Therapy and Its Determinants
por: Sidhu, Sukhmani, et al.
Publicado: (2021)

Is Chelation Therapy a Potential Treatment for Parkinson’s Disease?
por: Ward, Roberta J., et al.
Publicado: (2021)

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
por: Grolez, Guillaume, et al.
Publicado: (2015)

EDTA Chelation Therapy for the Treatment of Neurotoxicity
por: Fulgenzi, Alessandro, et al.
Publicado: (2019)

Optimizing Communication and Adherence to Iron Chelation Therapy From Diagnosis to Treatment in Patients With Myelodysplastic Syndromes
por: Shah, Jayshree, et al.
Publicado: (2016)

Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients
por: Parisi, Sarah, et al.
Publicado: (2021)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer
por: Kontoghiorghes, George J.
Publicado: (2022)

Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections
por: Chhabra, Ravneet, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i1gfihboofkqfej51351ojtrgd